Joaquin Gomez Moya, CEO at Ingeniatrics, visited on Monday 5th the facilities of the Group of Pharmaceutical Technology at the University of Seville. This group is led by Mercedes Fernandez Arevalo, vicedean of the University, and has achieved outstanding results in microencapsulation of insulin, for diabetes, and cannabinoids, for pain treatment, among other areas. Now they head towards further co-operation.
Flow Focusing has demonstrated advantageous at medicament microencapsulation for it improves monodispersion, all the microcapsules are of even diameter, is usable for many products and different sizes in the range from one micron to several hundreds micra, and allows a careful handling of said microcapsules. +info
Flow Focusing has demonstrated advantageous at medicament microencapsulation for it improves monodispersion, all the microcapsules are of even diameter, is usable for many products and different sizes in the range from one micron to several hundreds micra, and allows a careful handling of said microcapsules. +info
